PREVENT was conducted at 220 sites in the US, Europe, Latin America, and Asia Pacific. The study randomized 3700 patients hospitalized for medical illnesses to receive either 5000 IU of subcutaneous ...
Objective and Design: Tinzaparin and dalteparin are low molecular weight heparins (LMWHs) with different pharmacokinetic and pharmacodynamic profiles that may lead to differences in efficacy and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results